E-ISSN 2231-3206 | ISSN 2320-4672
 

Editorial

Online Publishing Date:
05 / 06 / 2013

 


Involvement of private players in pharmacovigilance program of India: Data reliability will be under question

Rajiv Mahajan.


Abstract
Pharmacovigilance or Adverse Drug Reactions (ADRs) monitoring is the pharmacological science related to the collection, detection, assessment, monitoring, and prevention of adverse effects or any other drug-related problem. India is fast growing as a hub of clinical trials. This is reflected in the fact that the total number of applications received and processed at Central Drug Standard Control Organization (CDSCO) New Delhi has doubled from around 10,000 in the Year 2005 to 22,806 in Year 2009; with increase in New Drug Applications, global clinical trials, and market authorization of vaccine and biotech products from 1200, 100, and 10 in Year 2005 to 1753, 262, and 137 in the Year 2009 respectively.

Key words: Pharmacovigilance, India, Private Players


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Rajiv Mahajan
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Rajiv Mahajan. Involvement of private players in pharmacovigilance program of India: Data reliability will be under question. Natl J Physiol Pharm Pharmacol. 2013; 3(2): 102-104. doi:10.5455/njppp.2013.3.290420131


Web Style

Rajiv Mahajan. Involvement of private players in pharmacovigilance program of India: Data reliability will be under question. https://www.njppp.com/?mno=36493 [Access: March 14, 2024]. doi:10.5455/njppp.2013.3.290420131


AMA (American Medical Association) Style

Rajiv Mahajan. Involvement of private players in pharmacovigilance program of India: Data reliability will be under question. Natl J Physiol Pharm Pharmacol. 2013; 3(2): 102-104. doi:10.5455/njppp.2013.3.290420131



Vancouver/ICMJE Style

Rajiv Mahajan. Involvement of private players in pharmacovigilance program of India: Data reliability will be under question. Natl J Physiol Pharm Pharmacol. (2013), [cited March 14, 2024]; 3(2): 102-104. doi:10.5455/njppp.2013.3.290420131



Harvard Style

Rajiv Mahajan (2013) Involvement of private players in pharmacovigilance program of India: Data reliability will be under question. Natl J Physiol Pharm Pharmacol, 3 (2), 102-104. doi:10.5455/njppp.2013.3.290420131



Turabian Style

Rajiv Mahajan. 2013. Involvement of private players in pharmacovigilance program of India: Data reliability will be under question. National Journal of Physiology, Pharmacy and Pharmacology, 3 (2), 102-104. doi:10.5455/njppp.2013.3.290420131



Chicago Style

Rajiv Mahajan. "Involvement of private players in pharmacovigilance program of India: Data reliability will be under question." National Journal of Physiology, Pharmacy and Pharmacology 3 (2013), 102-104. doi:10.5455/njppp.2013.3.290420131



MLA (The Modern Language Association) Style

Rajiv Mahajan. "Involvement of private players in pharmacovigilance program of India: Data reliability will be under question." National Journal of Physiology, Pharmacy and Pharmacology 3.2 (2013), 102-104. Print. doi:10.5455/njppp.2013.3.290420131



APA (American Psychological Association) Style

Rajiv Mahajan (2013) Involvement of private players in pharmacovigilance program of India: Data reliability will be under question. National Journal of Physiology, Pharmacy and Pharmacology, 3 (2), 102-104. doi:10.5455/njppp.2013.3.290420131